TD Securities analyst Sean Steuart downgraded Boralex (BRLXF) to Sell from Buy with a C$37.25 price target after the company entered into an agreement whereby Brookfield and La Caisse will acquire all of Boralex for a price of C$37.25 in cash per common share.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRLXF:
- Boralex to Go Private in $9 Billion Brookfield–La Caisse Deal to Accelerate Growth
- Boralex to be acquired by Brookfield and La Caisse for C$37.25 in cash per share
- Boralex confirms special committee formed to review alternatives
- Boralex Confirms Strategic Review While Reaffirming Core Renewable Strategy
- Boralex exploring deal to go private, Bloomberg reports